ENFUSION, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/8a7cecad-e9bd-44a2-addc-4bc4660d3dca/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2024 | $201.6M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-002043 |
| FY 2023 | $174.5M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-002987 |
| FY 2022 | $150.3M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-003450 |
| FY 2021 | $111.7M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-004676 |
| FY 2020 | $79.6M | 2020-01-01 – 2020-12-31 | evidence 0001558370-22-004676 |
| FY 2019 | $59.0M | 2019-01-01 – 2019-12-31 | evidence 0001558370-22-004676 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).